Table 2

Characteristics of patients continuing or stopping HCQ during follow-up

Continued HCQ
N=1029
Stopped HCQ
N=431
Female sex, N (%)911 (88.5)387 (89.8)
White race/ethnicity, N (%)574 (55.8)181 (42.0)
Mean age at SLE diagnosis (SD)35.3 (13.3)33.4 (13.0)
Centre, N (%)
 Canada264 (25.7)97 (22.5)
 USA331 (32.2)82 (19.0)
 Mexico41 (4.0)82 (19.0)
 UK196 (19.0)76 (17.6)
 Korea86 (8.4)61 (14.2)
 Other111 (10.8)33 (7.7)
  • HCQ, hydroxychloroquine.